Can I sell existing stock after an ingredient ban deadline?

No. Once a substance is added to Annex II (prohibited), products containing it cannot be placed on the market OR made available on the market after the deadline. This means existing retail stock must be removed. For Annex III/V/VI restrictions, there is typically a 6-month transition allowing sale of existing stock, but this does not apply to prohibitions.

How do I know if my fragrance contains a banned ingredient?

Request a detailed composition statement from your fragrance supplier that lists all components at or above 0.0001% (for allergen tracking). Many banned ingredients like Lilial or Galaxolide are fragrance compounds that may not appear in your declared INCI list but are present in 'parfum.' Your supplier should provide regulatory compliance declarations.

What happens if I continue selling products with banned ingredients?

Penalties vary by Member State but typically include: product seizure and withdrawal from market, fines (can exceed €50,000), reputational damage, and potential personal liability for the Responsible Person. Market surveillance authorities conduct testing and take enforcement action. Non-compliant products discovered in the supply chain can also affect retailer relationships.

Are there exemptions for natural or organic cosmetics?

No. The EU Cosmetics Regulation applies equally to all cosmetics regardless of natural, organic, or conventional positioning. If a banned substance occurs naturally in a botanical extract, the extract cannot be used if it causes the finished product to contain the prohibited substance above trace levels. Natural does not mean exempt from safety requirements.

How far in advance are new bans typically announced?

Transition periods vary. For Annex II additions (prohibitions), there is often minimal transition time once the regulation is published. For Annex III/V/VI modifications (restrictions), a 6-month transition is typical. Omnibus regulations are usually published 12-18 months before major deadlines, but monitoring SCCS opinions gives earlier warning of likely changes.

Will ingredient restrictions affect my CPSR?

Yes. If you reformulate to remove a banned ingredient, your CPSR must be updated to reflect the new composition. Even if you don't reformulate (because you already don't use the ingredient), your safety assessor should confirm compliance with current regulations. Annual CPSR reviews should verify all ingredients remain permitted.

Cosmetic Ingredient Ban 2025: EU Compliance Guide

Major Ingredient Changes Coming in 2025-2026

The EU cosmetics regulatory landscape is undergoing significant changes with multiple Omnibus Regulations adding new substance bans and restrictions. According to Obelis analysis, these changes stem from ongoing REACH evaluations and SCCS opinions identifying safety concerns.

Action Required

If your products contain any ingredients listed below, you must reformulate before the applicable deadline or cease sales in the EU. There are no exemptions for existing stock — products on shelves must comply by the deadline.

Omnibus VII: Effective September 1, 2025

According to Coslaw analysis, Omnibus VII (Regulation 2024/996) introduces:

Omnibus VII — Key Prohibitions (21 substances added to Annex II)
Substance	CAS Number	Category	Reason for Ban
2-Chloroethanol	107-07-3	Solvent/Intermediate	CMR classification (Carc. 1B, Repr. 1B)
2,4-Diaminodiphenylamine	136-17-4	Hair dye intermediate	CMR classification
4-[(4-Aminophenyl)(4-iminocyclohexa-2,5-dien-1-ylidene)methyl]-2-methylaniline	3248-93-9	Colorant/dye	CMR classification
Acid Green 25, CI 61570	4403-90-1	Colorant	CMR classification
Basic Red 51	77061-58-6	Hair colorant	CMR classification
Chloroacetamide	79-07-2	Preservative	CMR classification (Repr. 1B)
Disperse Violet 23	6408-72-6	Colorant	CMR classification
Solvent Violet 13, CI 60725	81-48-1	Colorant	CMR classification

* 21 total substances added to Annex II under Omnibus VII (Regulation EU 2025/877)

* Table shows representative examples — consult official regulation for complete list

Galaxolide (Hexamethylindanopyran) — Pending Classification

Galaxolide is currently under harmonized classification review for potential CMR 1B status. A ban is anticipated but NOT finalized. Monitor ECHA and Commission updates for the official classification decision before assuming prohibition.

Homosalate — RESTRICTION, Not Ban

Important Clarification: Homosalate is restricted, not banned. Per Regulation (EU) 2022/2195, it remains permitted under specific conditions: - Product types: Face products only (non-spray, pump spray) - Maximum concentration: 7.34% - Compliance: Products placed on market by January 1, 2025; made available by July 1, 2025 Homosalate is prohibited in body products and aerosol sprays, but compliant face sunscreens can continue to use it.

Omnibus VIII: Effective Throughout 2026

Per Coslaw and BeLab Services, Omnibus VIII (Regulation 2024/2052) introduces additional restrictions:

Lilial Ban — Already in Effect Since 2022

Critical Correction: Butylphenyl methylpropional (Lilial) was banned via Omnibus IV (Regulation EU 2021/1902) effective March 1, 2022 — over three years ago. Products containing Lilial have been prohibited from the EU market since that date. This is NOT a 2026 deadline.

Omnibus VIII — Key Restrictions Effective 2026
Substance	Deadline	Previous Status	New Status
Titanium dioxide (CI 77891) certain applications	Throughout 2026	Annex IV allowed	Restrictions for spray products
Various CMR substances (36+ entries)	March 2026	Previously unrestricted	Annex II prohibited
Certain azo dyes	2026	Allowed	New restrictions

CMR Substance Updates

The European Commission continues adding CMR (Carcinogenic, Mutagenic, Reprotoxic) substances to Annex II as they're classified under CLP Regulation. According to Article 15 of Regulation 1223/2009:

CMR Classification Impact

CMR Category 1A/1B substances are automatically prohibited in cosmetics
CMR Category 2 substances may be prohibited following SCCS evaluation
No transition period once listed in Annex II (prohibited)
Responsible Person must monitor CLP changes affecting ingredients
6-month transition period applies to Annex III/V/VI restrictions

Timeline of 2025-2026 Compliance Deadlines

Key Compliance Dates
Date	Regulation	Key Changes	Products Affected
March 1, 2022 (PAST)	Omnibus IV	Lilial fully banned	Perfumes, scented skincare — already prohibited
July 1, 2025	2022/2195	Homosalate restrictions (face products only, 7.34% max)	Sunscreens — restriction, not ban
September 1, 2025	Omnibus VII	21 substances prohibited	Hair dyes, colorants, fragranced products
July 31, 2026	2023/1545	New fragrance allergen labeling	All fragranced products (new products)
September 2026	Omnibus VIII	Additional CMR bans (36+ entries)	Various categories
July 31, 2028	2023/1545	Allergen labeling for existing products	All fragranced products

Impact by Product Category

Sunscreens and SPF Products

UV Filter Regulatory Changes
UV Filter	Current Status	2025 Status	Notes
Homosalate	Annex VI (previously 10%)	RESTRICTED to 7.34% face products only (July 2025)	Not banned — permitted in face products
Octocrylene	Under SCCS review	Awaiting opinion	Monitor closely
Benzophenone-3	Annex VI (up to 6%)	Lower limits in discussion	Alternative: Tinosorb S, Uvinul A Plus
Butyl Methoxydibenzoylmethane (Avobenzone)	Annex VI (up to 5%)	Stable, no changes planned	N/A

Sunscreen Reformulation

Sunscreen formulators should prioritize broad-spectrum protection using the latest approved filters. Consider encapsulated or photostabilized systems to maintain efficacy while complying with new restrictions.

Hair Colorants

Multiple hair dye intermediates face prohibition under Omnibus VII and VIII:

Hair Dye Ingredients Status
Ingredient	Deadline	Action Required
2,4-Diaminodiphenylamine	Sept 2025	Reformulate or discontinue
Basic Red 51	Sept 2025	Find alternative colorant
Various p-phenylenediamine derivatives	Ongoing	Verify current Annex III status
HC dyes (selected)	Various	Check individual entries

Fragranced Products

Fragrance Ingredient Changes
Ingredient	INCI Name	Status	Impact
Lilial	Butylphenyl methylpropional	BANNED since March 2022	Already prohibited — verify your fragrances are Lilial-free
Galaxolide	Hexamethylindanopyran	Under CMR review (pending)	Anticipate potential ban — monitor classification decision
80+ allergens	Various	July 2026/2028 labeling	Expanded labeling required above threshold

How to Prepare for Ingredient Bans

Compliance Action Plan

Audit Current Formulations

Review all product formulas against the upcoming ban lists. Check raw material specifications — some ingredients may be present as impurities or fragrance components rather than declared ingredients.

Identify Affected Products

Create a list of products requiring reformulation and prioritize by sales volume, deadline proximity, and reformulation complexity.

Source Alternatives

Work with ingredient suppliers to identify compliant alternatives. Request regulatory documentation confirming new ingredients are permitted under EU regulations.

Reformulate and Test

Develop new formulations, conduct necessary stability and safety testing. Allow adequate lead time for full testing programs.

Update CPSR and Documentation

Revise safety assessments for reformulated products. Update CPNP notifications and labels accordingly.

Plan Stock Transition

Calculate sell-through dates for existing inventory. Products on EU shelves must comply by the deadline — plan production and distribution accordingly.

Monitoring Future Changes

Stay Informed: Resources to Monitor

EUR-Lex for new Omnibus Regulations (search 'cosmetics regulation amendments')
SCCS opinions on ingredient safety (health.ec.europa.eu)
ECHA CLP notifications for new CMR classifications
CosIng database updates (ec.europa.eu/growth/tools-databases/cosing)
Industry associations: Cosmetics Europe, CTPA, national associations
Regulatory consultancy newsletters and alerts

Key Takeaways

Omnibus VII (Sept 2025) prohibits 21 substances including several hair dye intermediates and colorants

Homosalate is RESTRICTED (not banned) — permitted in face products only at 7.34% max from July 2025

Lilial was banned in March 2022 under Omnibus IV — this is NOT a new 2025-2026 deadline

Galaxolide is under CMR classification review — ban anticipated but not yet finalized

Omnibus VIII (2026) adds 36+ CMR substances to Annex II

CMR Category 1A/1B substances are automatically prohibited — monitor CLP updates

No sell-through period for Annex II prohibitions — products must comply by deadline

Start reformulation early — testing and CPSR updates require lead time